GRI Dividend: GRI Bio Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

GRI Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	4	4	8	5	4	1
Research & Development	5	--	3	1	5	3
Operating Expenses	10	8	11	6	9	4
Other Non Operating Income (Expenses)	0	0	0	0	0	--
Pretax Income	-10	-8	-13	-7	-9	-4
Income Tax Expense	--	--	--	--	--	--
Net Income	-11	-10	-13	-7	-9	-4
Net Income Growth	38%	-23%	86%	-22%	125%	33%
Shares Outstanding (Diluted)	2.2	0.18	0	0	0	0
Shares Change (YoY)	8,097%	8,629%	950%	100%	0%	0%
EPS (Diluted)	-5.4	-54.56	-6,237.79	-31,927.27	-62,020	-32,146.66
EPS Growth	-98%	-99%	-80%	-49%	93%	39%
Free Cash Flow	-9	-8	-8	-7	-8	-3
Free Cash Flow Per Share	-4.08	-43.64	-3,809.52	-35,000	-80,000	-30,000
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-10	-8	-11	-6	-9	-4
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-10	-8	-11	-6	-9	-4
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--